Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients

BACKGROUND: Glutamate dehydrogenase (GDH) is a key enzyme that catalyzes the final reaction of the glutamine metabolic pathway, and has been reported implicated in tumor growth and metastasis. However, it’s clinical significance and role in colorectal cancer (CRC) pathogenesis is largely unknown. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Gaojie, Zhu, Jie, Yu, Menglei, Cai, Canfeng, Zhou, Yu, Yu, Min, Fu, Zhiqiang, Gong, Yuanfeng, Yang, Bin, Li, Yingru, Zhou, Quanbo, Lin, Qin, Ye, Huilin, Ye, Liangtao, Zhao, Xiaohui, Li, Zhihua, Chen, Rufu, Han, Fanghai, Tang, Chaoming, Zeng, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490642/
https://www.ncbi.nlm.nih.gov/pubmed/25947346
http://dx.doi.org/10.1186/s12967-015-0500-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490642/
https://www.ncbi.nlm.nih.gov/pubmed/25947346
http://dx.doi.org/10.1186/s12967-015-0500-6

Ejemplares similares